Late-breaking abstracts submission deadline has passed
The San Antonio Breast Cancer Symposium is no longer accepting abstracts for 2025. The deadline for late-breaking abstract submission was 11:59 PM Central Time on Tuesday, September 30.
Decisions on those submissions by the abstract committees are expected by early November. Emails telling authors if the submission was accepted for presentation or not will be sent at that time to the primary (first) author on the abstract.
Spring abstract submission acceptances have been sent
SABCS abstract committee members have met and are making their decisions on presentations and posters for SABCS 2025. The first author of each abstract was sent an email with the decision..
Remember:
- Decision letters were sent in mid-September.
- Financial disclosures are be required upon acceptance.
- Presentation guidelines will be sent to the first author in October.
For answers to frequently asked questions, read our Abstract Guidelines (PDF)
Note: If you experience issues logging in, or have questions about the submission system, email sabcs@support.ctimeetingtech.com, or call +1 217-398-1792.
SABCS 2024 proceedings
The full proceedings of SABCS 2024 were published as a supplement to the June issue of Clinical Cancer Research, available from the American Association for Cancer Research. You can read all of the 2024 abstracts in the supplement online at Volume 31 Issue 12_Supplement | Clinical Cancer Research | American Association for Cancer Research
Confirmation of No Prior Publication/Presentation
Authors who submit an abstract confirm they have not previously published these data, they have not previously presented them at another scientific meeting, and that they are not planning to present or publish them prior to the dates of the SABCS® 2025. Preprints (draft research papers posted online before peer review) are not considered to be a prior publication if they are posted online before abstracts are submitted SABCS®.
Abstracts submitted to SABCS® are confidential and embargoed until SABCS® publishes the abstracts.
Certain laws may require disclosure of clinical trial data through federal and international registries within a specific amount of time following trial completion, or disclosure of clinical trial data by federal and international agencies for regulatory purposes related to drug safety and efficacy. Such disclosures will not be considered a violation of the SABCS’s Embargo Policy, but the courtesy of advance notice to the SABCS® by email at sabcs@uthscsa.edu is requested.
Any other exceptions to this policy are at the discretion of SABCS® leadership.
Copyright
All accepted abstracts, other than those that are withdrawn prior to publication and any that may have been accepted as a special late exception, will be published in the online Symposium proceedings, as an online only supplement in Clinical Cancer Research, and as SABCS Sessions and Poster Resources on the SABCS website. In addition, San Antonio Breast Cancer Symposium currently contracts with other parties to record and transcribe oral presentations for online slide review and streaming on the SABCS website. All of these resources are made available to the user at no charge.